JP2023536463A5 - - Google Patents
Info
- Publication number
- JP2023536463A5 JP2023536463A5 JP2023505923A JP2023505923A JP2023536463A5 JP 2023536463 A5 JP2023536463 A5 JP 2023536463A5 JP 2023505923 A JP2023505923 A JP 2023505923A JP 2023505923 A JP2023505923 A JP 2023505923A JP 2023536463 A5 JP2023536463 A5 JP 2023536463A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025186320A JP2026012422A (ja) | 2020-07-28 | 2025-11-05 | コンジュゲート型ヘプシジン模倣体 |
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063057582P | 2020-07-28 | 2020-07-28 | |
| US202063057574P | 2020-07-28 | 2020-07-28 | |
| US202063057583P | 2020-07-28 | 2020-07-28 | |
| US202063057577P | 2020-07-28 | 2020-07-28 | |
| US63/057,582 | 2020-07-28 | ||
| US63/057,583 | 2020-07-28 | ||
| US63/057,577 | 2020-07-28 | ||
| US63/057,574 | 2020-07-28 | ||
| US202163169515P | 2021-04-01 | 2021-04-01 | |
| US202163169533P | 2021-04-01 | 2021-04-01 | |
| US202163169527P | 2021-04-01 | 2021-04-01 | |
| US63/169,533 | 2021-04-01 | ||
| US63/169,515 | 2021-04-01 | ||
| US63/169,527 | 2021-04-01 | ||
| PCT/US2021/043579 WO2022026629A1 (en) | 2020-07-28 | 2021-07-28 | Conjugated hepcidin mimetics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025186320A Division JP2026012422A (ja) | 2020-07-28 | 2025-11-05 | コンジュゲート型ヘプシジン模倣体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023536463A JP2023536463A (ja) | 2023-08-25 |
| JP2023536463A5 true JP2023536463A5 (https=) | 2024-07-16 |
| JPWO2022026629A5 JPWO2022026629A5 (https=) | 2024-07-16 |
Family
ID=80036079
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505923A Pending JP2023536463A (ja) | 2020-07-28 | 2021-07-28 | コンジュゲート型ヘプシジン模倣体 |
| JP2023505864A Pending JP2023540679A (ja) | 2020-07-28 | 2021-07-28 | コンジュゲートされたヘプシジン模倣物 |
| JP2025186320A Pending JP2026012422A (ja) | 2020-07-28 | 2025-11-05 | コンジュゲート型ヘプシジン模倣体 |
| JP2025253353A Pending JP2026048851A (ja) | 2020-07-28 | 2025-12-16 | コンジュゲートされたヘプシジン模倣物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505864A Pending JP2023540679A (ja) | 2020-07-28 | 2021-07-28 | コンジュゲートされたヘプシジン模倣物 |
| JP2025186320A Pending JP2026012422A (ja) | 2020-07-28 | 2025-11-05 | コンジュゲート型ヘプシジン模倣体 |
| JP2025253353A Pending JP2026048851A (ja) | 2020-07-28 | 2025-12-16 | コンジュゲートされたヘプシジン模倣物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20240066131A1 (https=) |
| EP (2) | EP4188412A4 (https=) |
| JP (4) | JP2023536463A (https=) |
| KR (1) | KR20230053615A (https=) |
| AU (2) | AU2021315564A1 (https=) |
| CA (2) | CA3189432A1 (https=) |
| IL (1) | IL299530A (https=) |
| MX (1) | MX2023001292A (https=) |
| PH (1) | PH12023500004A1 (https=) |
| WO (3) | WO2022026631A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2968443T3 (da) | 2013-03-15 | 2021-12-06 | Protagonist Therapeutics Inc | Hepcidinanaloger og anvendelser deraf |
| PT3143037T (pt) | 2014-05-16 | 2021-09-24 | Protagonist Therapeutics Inc | Antagonistas peptídicos tioéter de integrina alfa4beta7 |
| US9624268B2 (en) | 2014-07-17 | 2017-04-18 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| EP3749345A4 (en) | 2018-02-08 | 2022-04-06 | Protagonist Therapeutics, Inc. | CONJUGATED HEPCIDIN MIMETICS |
| TW202019948A (zh) | 2018-07-12 | 2020-06-01 | 美商領導醫療有限公司 | 介白素-23受體之肽抑制劑及其治療發炎疾病之用途 |
| HRP20250769T1 (hr) | 2020-01-15 | 2025-08-29 | Janssen Biotech, Inc. | Peptidni inhibitori receptora za interleukin-23 i njihova uporaba u liječenju upalnih bolesti |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| WO2022159395A1 (en) | 2021-01-20 | 2022-07-28 | Viking Therapeutics, Inc. | Compositions and methods for the treatment of metabolic and liver disorders |
| US20240226225A1 (en) * | 2021-04-01 | 2024-07-11 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| AU2022249095A1 (en) * | 2021-04-01 | 2023-10-12 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| WO2023288019A2 (en) | 2021-07-14 | 2023-01-19 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of interleukin-23 receptor |
| MX2024003236A (es) | 2021-09-15 | 2024-06-19 | Viking Therapeutics Inc | Composiciones y metodos para el tratamiento de trastornos metabolicos y hepaticos. |
| EP4472996A4 (en) * | 2022-02-02 | 2025-11-26 | Protagonist Therapeutics Inc | Conjugated hepcidin mimetics |
| EP4472995A4 (en) * | 2022-02-02 | 2025-11-19 | Protagonist Therapeutics Inc | Conjugated hepcidin mimetics |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5993811A (en) * | 1997-02-03 | 1999-11-30 | Biology Associates, Llc | Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
| US6774212B2 (en) * | 1999-12-03 | 2004-08-10 | Bristol-Myers Squibb Pharma Company | Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease |
| WO2013086143A1 (en) * | 2011-12-09 | 2013-06-13 | The Regents Of The University Of California | Modified mini-hepcidin peptides and methods of using thereof |
| DK2968443T3 (da) * | 2013-03-15 | 2021-12-06 | Protagonist Therapeutics Inc | Hepcidinanaloger og anvendelser deraf |
| US9315545B2 (en) * | 2014-04-07 | 2016-04-19 | Merganser Biotech, Inc. | Hepcidin mimetic peptides and uses thereof |
| KR20170043509A (ko) * | 2014-06-27 | 2017-04-21 | 프로타고니스트 테라퓨틱스, 인코포레이티드 | 헵시딘 및 미니-헵시딘 유사체 및 그의 용도 |
| US20190002503A1 (en) * | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| WO2018128828A1 (en) * | 2016-12-23 | 2018-07-12 | Bayer Healthcare Llc | Novel hepcidin mimetics and uses thereof |
| EP3749345A4 (en) * | 2018-02-08 | 2022-04-06 | Protagonist Therapeutics, Inc. | CONJUGATED HEPCIDIN MIMETICS |
-
2021
- 2021-07-28 IL IL299530A patent/IL299530A/en unknown
- 2021-07-28 WO PCT/US2021/043581 patent/WO2022026631A1/en not_active Ceased
- 2021-07-28 CA CA3189432A patent/CA3189432A1/en active Pending
- 2021-07-28 EP EP21848536.5A patent/EP4188412A4/en active Pending
- 2021-07-28 US US18/018,481 patent/US20240066131A1/en active Pending
- 2021-07-28 JP JP2023505923A patent/JP2023536463A/ja active Pending
- 2021-07-28 US US18/018,482 patent/US20240018189A1/en active Pending
- 2021-07-28 WO PCT/US2021/043579 patent/WO2022026629A1/en not_active Ceased
- 2021-07-28 AU AU2021315564A patent/AU2021315564A1/en active Pending
- 2021-07-28 CA CA3188410A patent/CA3188410A1/en active Pending
- 2021-07-28 AU AU2021316000A patent/AU2021316000A1/en active Pending
- 2021-07-28 EP EP21849116.5A patent/EP4188413A4/en active Pending
- 2021-07-28 JP JP2023505864A patent/JP2023540679A/ja active Pending
- 2021-07-28 MX MX2023001292A patent/MX2023001292A/es unknown
- 2021-07-28 US US18/016,825 patent/US20230295259A1/en active Pending
- 2021-07-28 PH PH1/2023/500004A patent/PH12023500004A1/en unknown
- 2021-07-28 KR KR1020237006472A patent/KR20230053615A/ko active Pending
- 2021-07-28 WO PCT/US2021/043584 patent/WO2022026633A1/en not_active Ceased
-
2025
- 2025-11-05 JP JP2025186320A patent/JP2026012422A/ja active Pending
- 2025-12-16 JP JP2025253353A patent/JP2026048851A/ja active Pending